A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma

NCT01432951 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Lymphoma, Malignant

Interventions

DRUG: Enzastaurin

Sponsor

Eli Lilly and Company